ArticleJournal of hematology & oncology2017

Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies.

Kurt Schönfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.